Categories: News

GT Molecular Launches Highly Sensitive Multiplexed PCR Tests for the Indian Coronavirus Variant

FORT COLLINS, Colo., May 19, 2021 /PRNewswire/ — GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels for clinical labs, has started shipping its sensitive PCR tests to monitor the coronavirus variant, B.1.617. The virus was first spotted in India and upgraded to a global variant of concern by the WHO. It is sometimes referred to as the double mutant because it contains two mutations of concern and has been reported to be highly contagious and potentially capable of evading the immune system.

Two offerings are available:

  1. A national wastewater-based epidemiology testing service in which sewage from communities around the country is tested for the presence of the key mutations that define the B.1.617 double mutant variant from India.
  2. Ultrasensitive RT-PCR and dPCR reagent kits to empower academic, commercial, and public testing laboratories:
    1. Quantification and differentiation PCR kit for the B.1.617 variant
    2. Validated, quantitative standards and multiplex PCR assays for the original strain of Wuhan/WHO/4 (A), the UK variant (B.1.1.7), the South African variant (B.1.351), the Brazilian variant (P.1), the California variant (B.1.427) and the Indian variant (B.1.617).

These new offerings add to GT Molecular’s growing molecular assay catalog that includes SARS-CoV-2 multi-variant tests, cancer panels, multiplexed pathogen panels for clinical labs and quantitative standards.

About GT Molecular

GT Molecular is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests.  GTM’s molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.

ORDER & INFORMATION: info@gtmolecular.com,  970-498-1698

View original content:http://www.prnewswire.com/news-releases/gt-molecular-launches-highly-sensitive-multiplexed-pcr-tests-for-the-indian-coronavirus-variant-301295109.html

SOURCE GT Molecular

Staff

Recent Posts

Vivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & Sullivan

Vivalink honored for enabling technology leadership with its innovative remote patient monitoring solutions CAMPBELL, Calif.,…

11 minutes ago

UNC Health Wayne Includes MEDI+SIGN Digital Whiteboards in Their Mission to Enhance Patient Care

SMITHSBURG, Md., Jan. 9, 2025 /PRNewswire/ -- UNC Health Wayne, a leading healthcare institution committed…

11 minutes ago

Transforming Contact Centers: How GTS Helps Businesses Deliver Exceptional Customer Experiences with AI and Innovation

ALTA LOMA, Calif., Jan. 9, 2025 /PRNewswire/ -- GTSCX.AI – What does transforming a contact…

11 minutes ago

Annexus Health Rings In 2025 By Surpassing $6 Billion in Patient Financial Assistance Awards Secured

Driven by a network of more than 4,200 sites of care now using the AssistPoint®…

11 minutes ago

CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow

ALAMEDA, Calif., Jan. 9, 2025 /PRNewswire/ -- CellFE®, a leader in non-viral gene editing technology,…

12 minutes ago

Goertek Unveils Next-Generation Smart Ring Reference Designs: A Leap Forward in Health Monitoring and Interactive Technology

LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- Recent technological advancements in sensing, big data, cloud…

12 minutes ago